Science Education
>

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

PREPARACIÓN DEL INSTRUCTOR
CONCEPTOS
PROTOCOLO ESTUDIANTE
JoVE Revista
Biología
Se requiere una suscripción a JoVE para ver este contenido.  Inicie sesión o comience su prueba gratuita.
JoVE Revista Biología
Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

NOTE: All animal protocols were approved by the Johns Hopkins University Animal Care and Use Committee.

1. Animal Preparation

  1. Prepare 6 C57BL/6 control mice for the DFCO measurement, by anesthetizing them with ketamine and xylazine as outlined in step 2.3 below.
  2. Prepare all of the other mice with the different lung pathologies shown in Table 1 by using the same procedure as for the controls. Specific details needed to establish each of these models are found in the relevant references. Control mice and those in the other pathologic cohorts are all 6-12 weeks of age.

2. Measurement of Diffusion Factor for Carbon Monoxide (DFCO)

  1. Set up the gas chromatograph module supplied with the machine to measure peaks for nitrogen, oxygen, neon, and carbon monoxide. For this application use only the neon and CO data.
    NOTE: This instrument uses a molecular sieve column with helium as carrier gas, with a 12.00 µm film, 320.00 µm ID and 10 m length. The chromatograph column has a volume of 0.8 ml, but we used 2 ml to ensure adequate clearing of the connecting tubing with the sample.
  2. At the start of each experimental day, prior to making measurements of the samples from the mice, take a 2 ml sample directly from a gas mixture bag containing approximately 0.5% Ne, 0.5% CO, and balance air, and use this sample to calibrate the gas chromatograph.
  3. Anesthetize mice with ketamine (90 mg/kg) and xylazine (15 mg/kg), and confirm anesthesia by the absence of reflex motion. Apply veterinary ointment on the eyes to prevent dryness. Tracheostomize the mice with a stub needle cannula (18 G in adults or 20 G in very young mice).
    NOTE: The DFCO is completed in less than 10 min after anesthesia and prior to any mechanical ventilation or other procedures.
  4. In mice greater than 6 weeks of age, use a 3 ml syringe to withdraw 0.8 ml of gas from the gas mixture bag. Connect the syringe to the tracheal cannula and quickly inflate the lung. Using a metronome, count 9 sec, and then quickly withdraw the 0.8 ml (exhaled air).
  5. Dilute this withdrawn 0.8 ml exhaled air to 2 ml with room air, allow it to rest for at least 15 sec. Then inject the whole sample into the gas chromatograph for analysis.
  6. While analyzing this first DFCO sample, inflate the mouse lung with a second 0.8 ml from the gas mixture bag, and then process this sample identical to the first sample. Average the two DFCO measurements.
    NOTE: For measurements in mice as young as 2 weeks of age, use a volume of 0.4 ml, since 0.8 ml is too large a volume to make measurements in lungs of very young mice. It is better to use the 0.8 ml volume for mice older than 6 weeks, and that if the 0.4 ml volume is needed for some mice, it should be used consistently for all mice in the cohort being studied.
  7. Calculate DFCO as 1 – (CO9 / COc) / (Ne9 / Nec), where c and 9 subscripts refer to concentrations of the calibration gases injected and the gases removed after a 9 sec breath hold time, respectively.
  8. Analyze and compare differences with a one-way ANOVA and assess the significance level with Tukey’s correction for multiple comparisons in all the cohort mice. Consider p <0.05 as significant value.
    NOTE: All of the mice used here were part of experimental studies involving several subsequent measurements of lung ventilation, mechanics, lung lavage, or histology, which are not reported here. In addition, since the method is the same in all the experimental models as was done above in the control mice, only the results from the various pathologic models are presented. Further information on these models is presented in the supplemental table.
  9. Euthanize the animals by deep anesthetic overdose followed by cervical dislocation or decapitation. Where needed, remove the lung cells and/or tissues from the dead mice for further biologic or histologic processing and analysis.

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Learning Objectives

Figure 1 shows the DFCO measurements from the adult mice in groups A, B, C, D, E, and F. There were significant decreases with both the Aspergillus and influenza infections, as well as significant decreases in the fibrotic, emphysematous, and acute lung injury models. Figure 2 shows the Group G developmental changes in DFCO over time as the mice age from 2-6 weeks. There was a slight but significant increase with lung development over this time course. The effect of using a smaller inflation volume was also quite apparent at the 6 week time point. There was a tendency for the females to have a slightly higher DFCO, but this was only significant at the 5 week time point.

Group Pathology or Condition Comments
A C57BL/6 controls (8-10 weeks), n = 6 Healthy mice
B C57BL/6 mice given 25 TCID50 of influenza A virus (PR8) intranasally, n = 10 Influenza model, studied 6 and 8 days post-infection
C C57Bl/6 mice given 5.4 U pancreatic elastase intratracheally, n = 6 Emphysema model10,13 studied 21 days after elastase challenge
D C57BL/6 mice given 0.05 U bleomycin intratracheally, n = 6 Fibrosis model14 studied 14 days after bleomycin challenge
E CFTR null controls and those infected with aerosol inhalation of Aspergillus fumigatus (strain AF293), n = 6 Fungal infection model11,17 studied 12 days after fungal infection
F C57BL/6 mice given 3 µg/g BW LPS (Escherichia coli) intratracheally, n = 6 Acute Lung Injury (ALI) model15 studied on days 1 and 4 after the LPS insult
G C57BL/6 male mice at 2 to 6 weeks of age, n = 5 at each age Lung development model

Table 1: Listing of the different mouse models where the DFCO was measured.

Figure 1
Figure 1: Measurement of DFCO in the control C57BL/6 mice (Group A) and in each of the 5 different pathologic models. Shown are results 6 and 8 days after the PR8 influenza (Group B), 21 days after intratracheal elastase (Group C), 14 days after intratracheal bleomycin (Group D), 12 days after aspergillus infection in the CFTR null mice (Group E), and 1 and 4 days after LPS instillation (Group F). The * indicates P <0.01 vs. control, the # indicates P <0.01 between the 6 and 8 day influenza mice and the 1 and 4 day LPS mice, and the + indicates P <0.05 vs. control.

Figure 2
Figure 2: Measurement of DFCO in male C57BL/6 mice from 2 through 6 weeks of age (Group G). The measurements were made in all mice with an inflation volume of 0.4 ml, and in the 6 week old mice a second measurement was made with 0.8 ml. With the 0.4 ml volume, there were significant increases in DFCO between the 2 week male and those at 4, 5, and 6 weeks (P <0.05).

List of Materials

Gas Chromatograph Inficon Micro GC Model 3000A Agilent makes a comparable model
18 g Luer stub needle Becton Dickenson Several other possible vendors
3 mL plastic syringe Becton Dickenson Several other possible vendors
Polypropylene gas sample bags SKC 1 or 2 liter capacity works well Other gas tight bags will work well
Gas tank, 0.3% Ne,0.3% CO, balance air; (size ME) Airgas, Inc Z04 NI785ME3012 This is the standard mixture used for DLCO in humans
25 TCID50/mouse of influenza virus A/PR8 diluted in phosphate buffered saline.
Porcine pancreatic elastase Elastin Products, Owensville, MO 5.4 U
Bleomycin APP Pharmaceuticals, Schaumburg, IL 0.25 U
Escherichia coli LPS8 Sigma L2880 3 μg/g body weight; O55:B5
Aspergillus fumigatus (isolate Af293) conidia were collected from mature colonies grown on potato dextrose agar.

Lab Prep

The mouse is now the primary animal used to model a variety of lung diseases. To study the mechanisms that underlie such pathologies, phenotypic methods are needed that can quantify the pathologic changes. Furthermore, to provide translational relevance to the mouse models, such measurements should be tests that can easily be done in both humans and mice. Unfortunately, in the present literature few phenotypic measurements of lung function have direct application to humans. One exception is the diffusing capacity for carbon monoxide, which is a measurement that is routinely done in humans. In the present report, we describe a means to quickly and simply measure this diffusing capacity in mice. The procedure involves brief lung inflation with tracer gases in an anesthetized mouse, followed by a 1 min gas analysis time. We have tested the ability of this method to detect several lung pathologies, including emphysema, fibrosis, acute lung injury, and influenza and fungal lung infections, as well as monitoring lung maturation in young pups. Results show significant decreases in all the lung pathologies, as well as an increase in the diffusing capacity with lung maturation. This measurement of lung diffusing capacity thus provides a pulmonary function test that has broad application with its ability to detect phenotypic structural changes with most of the existing pathologic lung models.

The mouse is now the primary animal used to model a variety of lung diseases. To study the mechanisms that underlie such pathologies, phenotypic methods are needed that can quantify the pathologic changes. Furthermore, to provide translational relevance to the mouse models, such measurements should be tests that can easily be done in both humans and mice. Unfortunately, in the present literature few phenotypic measurements of lung function have direct application to humans. One exception is the diffusing capacity for carbon monoxide, which is a measurement that is routinely done in humans. In the present report, we describe a means to quickly and simply measure this diffusing capacity in mice. The procedure involves brief lung inflation with tracer gases in an anesthetized mouse, followed by a 1 min gas analysis time. We have tested the ability of this method to detect several lung pathologies, including emphysema, fibrosis, acute lung injury, and influenza and fungal lung infections, as well as monitoring lung maturation in young pups. Results show significant decreases in all the lung pathologies, as well as an increase in the diffusing capacity with lung maturation. This measurement of lung diffusing capacity thus provides a pulmonary function test that has broad application with its ability to detect phenotypic structural changes with most of the existing pathologic lung models.

Procedimiento

The mouse is now the primary animal used to model a variety of lung diseases. To study the mechanisms that underlie such pathologies, phenotypic methods are needed that can quantify the pathologic changes. Furthermore, to provide translational relevance to the mouse models, such measurements should be tests that can easily be done in both humans and mice. Unfortunately, in the present literature few phenotypic measurements of lung function have direct application to humans. One exception is the diffusing capacity for carbon monoxide, which is a measurement that is routinely done in humans. In the present report, we describe a means to quickly and simply measure this diffusing capacity in mice. The procedure involves brief lung inflation with tracer gases in an anesthetized mouse, followed by a 1 min gas analysis time. We have tested the ability of this method to detect several lung pathologies, including emphysema, fibrosis, acute lung injury, and influenza and fungal lung infections, as well as monitoring lung maturation in young pups. Results show significant decreases in all the lung pathologies, as well as an increase in the diffusing capacity with lung maturation. This measurement of lung diffusing capacity thus provides a pulmonary function test that has broad application with its ability to detect phenotypic structural changes with most of the existing pathologic lung models.

Tags